0001643918-24-000001.txt : 20240104 0001643918-24-000001.hdr.sgml : 20240104 20240103190106 ACCESSION NUMBER: 0001643918-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240104 DATE AS OF CHANGE: 20240103 EFFECTIVENESS DATE: 20240104 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Biodexa Pharmaceuticals Plc CENTRAL INDEX KEY: 0001643918 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-501496 FILM NUMBER: 24509037 BUSINESS ADDRESS: STREET 1: 1 CASPIAN POINT STREET 2: CASPIAN WAY CITY: CARDIFF STATE: X0 ZIP: CF10 4DQ BUSINESS PHONE: 44 (0)1235 888300 MAIL ADDRESS: STREET 1: 1 CASPIAN POINT STREET 2: CASPIAN WAY CITY: CARDIFF STATE: X0 ZIP: CF10 4DQ FORMER COMPANY: FORMER CONFORMED NAME: Midatech Pharma Plc DATE OF NAME CHANGE: 20150602 D 1 primary_doc.xml X0708 D LIVE 0001643918 Biodexa Pharmaceuticals Plc 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 UNITED KINGDOM CF10 4DQ 44 (0)1235 888300 UNITED KINGDOM Midatech Pharma Plc Other Public limited company organized under the laws of England and Wales. true Stephen Stamp c/o Biodexa Pharmaceuticals Plc 1 Caspian Point, Caspian Way Cardiff X0 UNITED KINGDOM CF10 4DQ Executive Officer Director Simon Turton c/o Biodexa Pharmaceuticals Plc 1 Caspian Point, Caspian Way Cardiff X0 UNITED KINGDOM CF10 4DQ Director Stephen Parker c/o Biodexa Pharmaceuticals Plc 1 Caspian Point, Caspian Way Cardiff X0 UNITED KINGDOM CF10 4DQ Director Sijmen de Vries c/o Biodexa Pharmaceuticals Plc 1 Caspian Point, Caspian Way Cardiff X0 UNITED KINGDOM CF10 4DQ Director Dmitry Zamoryakhin c/o Biodexa Pharmaceuticals Plc 1 Caspian Point, Caspian Way Cardiff X0 UNITED KINGDOM CF10 4DQ Executive Officer Pharmaceuticals Decline to Disclose 06b false 2023-12-21 false true true true false 0 6793406 6793406 0 false 1 0 0 0 false Biodexa Pharmaceuticals Plc /s/ Stephen Stamp Stephen Stamp CEO and CFO 2024-01-03